Clinical trial
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and…
NCT00176826 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00176826 |
|---|---|
| Title | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders |
| Official title | In-vivo T-cell Depletion and Hematopoietic Stem Cell Transplantation for Life-Threatening Immune Deficiencies and Histiocytic Disorders |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Diseases, Langerhans-Cell Histiocytosis, Hematologic Diseases |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplant, Myeloablative conditioning regimen |
| Enrollment | 22 |
| Start date | Sep 1, 2000 |
| Primary completion | Aug 1, 2012 |
| Completion | Aug 1, 2015 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: